Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRENA: Thiamine to Reduce Brain Injury in Alcohol Use Disorder
2025-524148-36-00Phase 2Authorised
- Sponsor
- Inserm
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of thiamine in alcohol use disorder (AUD) (2 arms), sponsored by Inserm. Primary endpoint: Primary endpoint: change in plasma neurofilament light chain (NFL). Planned start Nov 2026; status: authorised.
02
Drugs
thiamine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2025-524148-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524148-36-00.